Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Overzicht 
Osagie O. Imasogie is an entrepreneur and businessperson who founded 9 companies, which include: Phoenix IP Ventures LLC, Churchill Pharmaceuticals and Ilera Healthcare LLC and who has been at the head of 10 different companies. Currently, he holds the position of Chairman at Zelira Therapeutics Ltd., Chairman at Ilera Therapeutics LLC (a subsidiary of Zelira Therapeutics Ltd.), Chairman & Chief Executive Officer at Ibere Pharmaceuticals, Senior Managing Partner at Phoenix IP Ventures LLC (which he founded in 2010), Chairman of Ilera Healthcare LLC (which he founded in 2016) and Advisor at Ben Franklin Technology Partners. Mr. Imasogie is also Chairman at The University of Pennsylvania Law School, Attorney at Schnader Harrison Segal & Lewis LLP, Member of New York State Bar Association, Member of Wilson Council and Senior Managing Partner at Pipv Capital (he founded the company in 2004) and on the board of 9 other companies.

In the past he occupied the position of Chairman for Churchill Pharmaceuticals (he founded the company), EVP-Global Corporation Development at Dr. Reddy's Laboratories Ltd. and Chairman at Trigenesis Therapeutics, Inc. (a subsidiary of Dr. Reddy's Laboratories Ltd.), Founding Vice President at GSK Venture Fund, Chairman at iCeutica, Inc. (he founded the company), Chairman for Ception Therapeutics, Inc. (he founded the company in 2004), Chairman at Iroko Pharmaceuticals LLC (he founded the company), Partner-Corporate Finance at Pricewaterhouse & Co., VP & Director-Product Development Strategy at Smithkline Beckman Corp, VP, Director-Genetics & Discovery Venture at GlaxoSmithKline Research & Development, VP-International Sales & Marketing at DuPont Merck Pharmaceutical Co. and SVP-Business Development & General Counsel at Endo Pharmaceuticals, Inc. (he founded the company in 1997).

He received a graduate degree from London School of Economics & Political Science and a graduate degree from The University of Pennsylvania Law School.


Posities en verantwoordelijkheden van Osagie O. Imasogie 
NaamTitel Van
FS KKR Capital Corp.
(Gesloten eindfondsen)
Independent Director 2019
FS KKR Capital Corp. II
(Beleggingsfondsen)
Independent Director 2019
Ibere Pharmaceuticals
(Holdingvennootschappen)
Chairman & Chief Executive Officer -
Zelira Therapeutics Limited
(Biotechnologie & Medisch Onderzoek)
Chairman 2019
Ilera Therapeutics LLC Chairman -
Ilera Healthcare LLC Chairman 2016
The University of Pennsylvania Law School Chairman -
Ben Franklin Technology Partners of Southeastern Pennsylvania Director -
Trustees of The University of Pennsylvania Trustee -
Beltraith Capital LLC Director -
The Philadelphia Museum of Art Director -
The Philadelphia Orchestra Association Director -
University City Science Center Director 2010
University of Pennsylvania Trustee -
Wilson Council Member -
New York State Bar Association Member -
Schnader Harrison Segal & Lewis LLP Attorney -
Pipv Capital Senior Managing Partner 2004
Phoenix IP Ventures LLC Co-Founder & Senior Managing Partner 2011
Ben Franklin Technology Partners /Ventures/ Advisor 2011


Belangnemingen van Osagie O. Imasogie 
NaamAandelen%Totale waarde
FS KKR Capital Corp. (FSK)
(Gesloten eindfondsen)
48 4880,017%1 015 339 USD
Zelira Therapeutics Limited (ZLD)
(Biotechnologie & Medisch Onderzoek)
16 413 0651,29%393 749 USD


Osagie O. ImasogiePersoonlijk netwerk 
Meest gelezen nieuws 
18/01ELON MUSK : Telsa-investeerders dringen er bij rechter op aan Musk te bevelen $13 mrd terug te betalen voor SolarCity-deal
MR
14/01JACK DORSEY : Jack Dorsey's Block om een open bitcoin mijnbouw systeem te bouwen
MR
14/01ELON MUSK : Tesla koopwaar koopbaar met dogecoin, zegt Musk in tweet
MR
27/01ELON MUSK : dit jaar geen menselijke chauffeurs, robots volgend
MR
20/01ALAN JOPE : Aandelen Unilever stijgen na afzien bod op activa GSK
MR
27/01BERNARD ARNAULT : LVMH heeft prijszettingsvermogen om inflatie tegen te gaan, maar moet redelijk zijn-Arnault
MR
25/01JOHN HESS : Hess verhoogt productiebudget met 37%
MR
19/01HAL BARRON : GSK hoofd wetenschapper Barron vertrekt naar VS biotech start-up
MR
23/01NELSON PELTZ : Activist Peltz bouwt belang op in Unilever - media
AM
27/01EDWARD ROGERS : Canada's Rogers Communications overtreft kwartaalomzetramingen
MR
Meer nieuws


© 2022 People and Ownership :   
Osagie O. Imasogie Verbindingen